Dextroprotiline acts as a [[potency (pharmacology)|potent]] [[norepinephrine reuptake inhibitor]]<ref name="pmid7115436">{{cite journal |vauthors=Waldmeier PC, Baumann PA, Hauser K, Maitre L, Storni A | title = Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer | journal = [[Biochemical Pharmacology (journal)|Biochemical Pharmacology]] | volume = 31 | issue = 12 | pages = 2169–76 |date=June 1982 | pmid = 7115436 | doi = 10.1016/0006-2952(82)90510-X| url = }}</ref><ref name="pmid8382162">{{cite journal |vauthors=Reimann IW, Firkusny L, Antonin KH, Bieck PR | title = Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man | journal = European Journal of Clinical Pharmacology | volume = 44 | issue = 1 | pages = 93–5 | year = 1993 | pmid = 8382162 | doi = 10.1007/BF00315288| url = }}</ref> and [[H1 receptor|H<sub>1</sub> receptor]] [[receptor antagonist|antagonist]],<ref name="pmid1353628">{{cite journal |vauthors=Noguchi S, Inukai T, Kuno T, Tanaka C | title = The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking | journal = Physiology & Behavior | volume = 51 | issue = 6 | pages = 1123–7 |date=June 1992 | pmid = 1353628 | doi = 10.1016/0031-9384(92)90297-F| url = }}</ref> as well as a very weak [[a1-adrenergic receptor|α<sub>1</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]].<ref name="pmid7115436" /><ref name="pmid6086881">{{cite journal |vauthors=Richelson E, Nelson A | title = Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 230 | issue = 1 | pages = 94–102 |date=July 1984 | pmid = 6086881 | doi = | url = http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=6086881}}</ref> It has negligible [[affinity (pharmacology)|affinity]] for the [[serotonin transporter]],<ref name="pmid7115436" /> [[dopamine transporter]], [[a2-adrenergic receptor|α<sub>2</sub>-adrenergic receptor]],<ref name="pmid7115436" /><ref name="pmid6086881" /> and [[muscarinic acetylcholine receptor]]s.<ref name="pmid6086881" /> Whether it has any [[receptor antagonist|antagonistic]] effects on the [[5-HT2 receptor|5-HT<sub>2</sub>]], [[5-HT7 receptor|5-HT<sub>7</sub>]], or [[D2 receptor|D<sub>2</sub> receptor]]s like its relative [[maprotiline]] is unclear.

 
Oxaprotiline is a [[racemic]] compound composed of two [[isomer]]s, ''R''(−)- or [[Levorotation|levo]]- oxaprotiline ('''levoprotiline'''; '''CGP-12,103-A'''), and ''S''(+)- or dextro- oxaprotiline ('''dextroprotiline'''; '''CGP-12,104-A'''). Both enantiomers are active, with the levo- form acting as an [[antihistamine]] and the dextro- form having a additional pharmacology (see [[Oxaprotiline#Pharmacology|above]]), but with both unexpectedly still retaining antidepressant effects.<ref name="pmid1530672">{{cite journal |vauthors=Noguchi S, Fukuda Y, Inukai T | title = Possible contributory role of the central histaminergic system in the forced swimming model | journal = Arzneimittel-Forschung | volume = 42 | issue = 5 | pages = 611–3 |date=May 1992 | pmid = 1530672 | doi = | url = }}</ref>
